Clinical Trial

Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Adenoma detection rate (ADR) is considered the single most important quality measure in colonoscopy and a higher ADR can reduce the risk of interval colorectal cancer (CRC). Several kinds of new endoscopes and accessories have been accessed to investigate the abilities of improving the ADR. Artificial intelligence (AI) and Endocuff vision are promising new devices to improve the ADR. However, the effect of combining AI and Endocuff vision on ADR remains unclear. The aim of this prospective randomized study is to compare the ADR of AI plus Endocuff vision, AI alone and standard colonoscopy examination.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-09.
Trial Details
NCT Number NCT05863208
Lead Sponsor E-DA Hospital
Collaborators: Chung Shan Medical University
Conditions Adenoma Detection Rate
Enrollment 1,000 participants
Start Date 2023-05-02
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-27